These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3944476)

  • 21. [Comparison of the action of pristan and Freund's incomplete adjuvant on the development of ascites in mice--the recipients of hybridoma cells].
    Novikov VV; Trofimova MN; Zhil'tsova MA; Sandova OM
    Antibiot Khimioter; 1988 Jul; 33(7):530-2. PubMed ID: 3190349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scale-up production and characterization of anti-human cardiac troponin I monoclonal antibody in ascitic fluid of balb/c mice.
    Majid AR; Javad RM; Malihe P; Javad M
    J Immunoassay Immunochem; 2017; 38(4):389-399. PubMed ID: 28026995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Vaseline-peptone mixture as a stimulant of ascites formation in mouse hybridoma carriers].
    Baryshnikov AIu; Trofimova MN; Novikov VV; Polianskaia GA; Sandova OM
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Mar; (3):90-3. PubMed ID: 3291501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dialysis-based bioreactor systems for the production of monoclonal antibodies--alternatives to ascites production in mice.
    Bruce MP; Boyd V; Duch C; White JR
    J Immunol Methods; 2002 Jun; 264(1-2):59-68. PubMed ID: 12191510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of priming and inoculation dose on the production of monoclonal antibodies in two age groups of BALB/c mice.
    De Deken R; Brandt J; Ceulemans F; Geerts S; Beudeker R
    Hybridoma; 1994 Feb; 13(1):53-7. PubMed ID: 8200659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of a hybridoma cell line secreting retinoic acid-specific monoclonal antibody.
    Zhou HR; Abouzied MM; Zile MH
    J Immunol Methods; 1991 Apr; 138(2):211-23. PubMed ID: 2033274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation of monoclonal antibodies reactive with beta-1,2-linked oligomannosyl residues in the phosphomannan-protein complex of Candida albicans NIH B-792 strain.
    Tojo M; Shibata N; Kobayashi M; Mikami T; Suzuki M; Suzuki S
    Clin Chem; 1988 Mar; 34(3):539-43. PubMed ID: 3280163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal antibodies to the chemotherapeutic agent methotrexate: production, properties and comparison with polyclonal antibodies.
    Kato Y; Paterson A; Langone JJ
    J Immunol Methods; 1984 Mar; 67(2):321-36. PubMed ID: 6707474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production and preliminary characterization of monoclonal antibodies to Actinobacillus sp isolated from epididymitis lesions in a ram.
    Healey MC; Kleinschuster SJ; Gharpure HM; Johnston AV
    Am J Vet Res; 1985 Jun; 46(6):1297-302. PubMed ID: 3896068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoclonal antibody to 2-amino-3-methylimidazo(4,5-f)quinoline, a dietary carcinogen.
    Yanagisawa H; Tachikawa T; Shin S; Wada O
    Appl Biochem Biotechnol; 1990 Jan; 23(1):1-13. PubMed ID: 2301946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of murine ascites on the ability of hybridoma cells to produce antibody and proliferate in vitro.
    Lumanglas AL; Wang BS
    Hybridoma; 1993 Feb; 12(1):127-33. PubMed ID: 8454299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Some ascites monoclonal antibody preparations contain contaminants that bind to selected Golgi zones or mast cells.
    Spicer SS; Spivey MA; Ito M; Schulte BA
    J Histochem Cytochem; 1994 Feb; 42(2):213-21. PubMed ID: 7507139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of monoclonal antibodies in the miniPERM bioreactor: comparison with other hybridoma culture methods.
    Falkenberg FW
    Res Immunol; 1998; 149(6):560-70. PubMed ID: 9835419
    [No Abstract]   [Full Text] [Related]  

  • 34. A porcine-murine hybridoma that secretes porcine monoclonal antibody of defined specificity.
    Raybould TJ; Willson PJ; McDougall LJ; Watts TC
    Am J Vet Res; 1985 Aug; 46(8):1768-9. PubMed ID: 3898933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Conditions for forming ascitic tumors in hybridoma cultivation in vivo].
    Novokhatskiĭ AS; Malakhova IV; Gaĭdamovich SIa; Mel'nikova EE; Sveshnikova NA
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Jul; (7):13-7. PubMed ID: 3751404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mice ascites as a source of polyclonal and monoclonal antibodies.
    Mahana W; Paraf A
    J Immunol Methods; 1993 May; 161(2):187-92. PubMed ID: 8505548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A human hybrid myeloma for production of human monoclonal antibodies.
    Kozbor D; Tripputi P; Roder JC; Croce CM
    J Immunol; 1984 Dec; 133(6):3001-5. PubMed ID: 6092464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and characterization of monoclonal antibodies against human IgA in Balb/c mice.
    Ezzatifar F; Majidi J; Baradaran B; Maleki LA; Abdolalizadeh J; Yousefi M
    Hum Antibodies; 2014; 23(1-2):7-12. PubMed ID: 25812697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production and characterization of monoclonal antibodies against human IgG in Balb/c mouse.
    Majidi J; Baradaran B; Hassan ZM; Mostafaie A
    Hum Antibodies; 2005; 14(1-2):1-5. PubMed ID: 16424594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Isolation and properties of hybridomas producing monoclonal antibodies to the Leningrad-16 measles virus].
    Andzhaparidze OG; Nagieva FG; Mal'tseva NN; Vedunova SL; Zvonarev AIu
    Vopr Virusol; 1989; 34(2):204-8. PubMed ID: 2669335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.